266 patents currently held
16 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.
The next term ends in Dec 2026. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
47
Ending by 2030
Dec 2026
Next term end
225
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Feb 2039 · High confidence
Also notable
Ends Apr 2037 · High confidence
Also notable
Ends Jan 2035 · High confidence
Production of Guaiene and Rotundone
US 11,485,985
Cited by 4 later US patents, top 25% of utility patents granted in 2022 in our data. Protection runs to 2039.
Solid Form of (-)-Ambrox Formed by a Bioconversion of Homofarnesol in the Presence of a Biocatalyst
US 10,844,412
A family of 6 related applications built on the 2020 grant. Protection runs to 2037.
Improvements in or Relating to Organic Compounds
US 10,196,414
Granted 2019 and renewed at 2 of 3 maintenance windows. Protection runs to 2035.
Formerly held, still cited
Notable
Ends Apr 2036 · High confidence
A family of 6 related applications built on the 2019 grant. Protection runs to 2036. A terminal disclaimer caps this term to an earlier patent's.
now held by Proteus S.A.
Also notable
Ends Aug 2035 · High confidence
A family of 6 related applications built on the 2019 grant. Protection runs to 2035.
now held by Manus Bio Inc.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 3 fees due Nov 23 to 28, 2026 · next Nov 23
- 1 fee due Dec 11, 2026The maintenance fee for Organic Compounds (US 10,315,976) comes due Dec 11, 2026. Unpaid by Jun 11, 2027, it lapses early.
- 2 fees due Jan 9 to 16, 2027 · next Jan 9
- 3 fees due Feb 11 to 18, 2027 · next Feb 11
- 6 fees due Mar 1 to 26, 2027 · next Mar 1
- 8 fees due Apr 3 to 30, 2027 · next Apr 3
- 4 fees due May 5 to 24, 2027 · next May 5
- 3 fees due Jun 3 to 5, 2027 · next Jun 3
- 4 fees due Jul 16 to 28, 2027 · next Jul 16
- 3 fees due Aug 25 to 27, 2027 · next Aug 25
- 5 fees due Sep 3 to 19, 2027 · next Sep 3
- 5 fees due Oct 7 to 28, 2027 · next Oct 7
- 2 fees due Nov 12 to 14, 2027 · next Nov 12
Recent changes
- Nov 12Assignment recorded on 1 record: Moll, Victor Hugo and 2 others to Givaudan S.A. Recorded Nov 12, 2026, executed Sep 13, 2026. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76725, frame 786.
- Nov 5Assignment recorded on 1 record: Blondeau, Philippe and 4 others to Givaudan S.A. Recorded Nov 5, 2026, executed Sep 30, 2026. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76647, frame 142.
- 7 of the patents on this record were granted since Aug 17, 2026
- 4 terms have ended since Aug 17, 2026
What they patent
The 5 largest of its 225 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Solid Form of (-)-Ambrox Formed by a Bioconversion of Homofarnesol in the Presence of a Biocatalyst | 4 in force | to Apr 2037 |
| Encapsulation | 4 in force | to Feb 2036 |
| Organic Compounds (2014) | 4 in force | to Nov 2033 |
| Method Related to Organic Compositions | 3 in force | to Jun 2041 |
| Organic Compounds (2015) | 3 in force | to May 2034 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,605,118 | Cyclooct-(EN-)yl Derivatives for Use as Fragrances In force · High confidence | In force | High confidence | |
| US 7,655,701 | Cycloalkylidene-(ortho Substituted Phenyl)-Acetonitriles and Their Use as Odorants In force · High confidence | In force | High confidence | |
| US 10,221,136 | Pyridinyl Cyclohexanecarboxamide Cooling Compounds In force · Medium confidence | In force | Medium confidence | |
| US 9,057,041 | Fragrance Compounds In force · Medium confidence | In force | Medium confidence | |
| US 9,585,362 | Fragrance Compounds In force · Medium confidence | In force | Medium confidence | |
| US 7,964,376 | Chimeric Proteins and Their Use in Methods to Screen for Sweet Taste Modulators In force · High confidence | In force | High confidence | |
| US 8,124,361 | Methods of screening for sweet taste modulators In force · High confidence | In force | High confidence | |
| US 9,011,829 | Perfume Compositions held by Givaudan Nederland Services B.V. In force · Medium confidence | In force | Medium confidence | |
| US 10,722,607 | Perfume Compositions In force · Medium confidence | In force | Medium confidence | |
| US 8,039,233 | Nucleic Acid Sequences and Their Use in Methods to Identify Umami Modulatiors In force · High confidence | In force | High confidence |
Also on record, not counted in the 266: 16 patents in force now held by others · 94 patents ended · 229 applications pending · 240 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.